Free Trial

CAMP4 Therapeutics (CAMP) Insider Trading & Ownership

CAMP4 Therapeutics logo
$4.38 -0.12 (-2.67%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$4.51 +0.13 (+3.06%)
As of 07:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CAMP4 Therapeutics (NASDAQ:CAMP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
33.60%
Number Of
Insiders Buying
(Last 12 Months)
7
Amount Of
Insider Buying
(Last 12 Months)
$8.55M
Number Of
Insiders Selling
(Last 12 Months)
0
Get CAMP Insider Trade Alerts

Want to know when executives and insiders are buying or selling CAMP4 Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CAMP Insider Buying and Selling by Quarter

CAMP4 Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/11/2025
5Am Partners Vi, Llc
Major Shareholder
Buy2,941,176$1.53$4,499,999.28  
9/11/2025
Amir Nashat
Director
Buy1,307,189$1.53$1,999,999.17  
9/11/2025
Josh Mandel-Brehm
CEO
Buy6,060$1.65$9,999.00  
9/11/2025
Kelly Gold
CFO
Buy6,060$1.65$9,999.00  
9/11/2025
Polaris Management Co. Vii, L.
Major Shareholder
Buy1,307,189$1.53$1,999,999.17  
9/11/2025
Richard A Young
Director
Buy15,151$1.65$24,999.15  
9/11/2025
Yuri Maricich
Insider
Buy6,060$1.65$9,999.00  
(Data available from 1/1/2013 forward)

CAMP Insider Trading Activity - Frequently Asked Questions

The list of insiders at CAMP4 Therapeutics includes 5Am Partners Vi, Llc, Amir Nashat, Jason Cohenour, Josh Mandel-Brehm, Kelly Gold, Polaris Management Co. Vii, L., Richard A Young, and Yuri Maricich. Learn more on insiders at CAMP.

33.60% of CAMP4 Therapeutics stock is owned by insiders. Learn more on CAMP's insider holdings.

The following insiders have purchased CAMP shares in the last 24 months: 5Am Partners Vi, Llc ($4,499,999.28), Amir Nashat ($1,999,999.17), Josh Mandel-Brehm ($9,999.00), Kelly Gold ($9,999.00), Polaris Management Co. Vii, L. ($11,999,989.17), Richard A Young ($24,999.15), and Yuri Maricich ($9,999.00).

Insiders have purchased a total of 6,497,975 CAMP shares in the last 24 months for a total of $18,554,983.77 bought.

The following insider sold CAMP shares in the last 24 months: Jason Cohenour ($7,171.20).

Insiders have sold a total of 8,640 CAMP4 Therapeutics shares in the last 24 months for a total of $7,171.20 sold.



This page (NASDAQ:CAMP) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners